Folgen
Fatemeh Kazemi-Lomedasht
Fatemeh Kazemi-Lomedasht
Associate Professor, Medical Biotechnology, Pasteur Institute of Iran
Bestätigte E-Mail-Adresse bei pasteur.ac.ir - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Single-domain antibodies or nanobodies: a class of next-generation antibodies
F Khodabakhsh, M Behdani, A Rami, F Kazemi-Lomedasht
International reviews of immunology 37 (6), 316-322, 2018
962018
Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody
F Kazemi-Lomedasht, M Behdani, KP Bagheri, M Habibi-Anbouhi, ...
Molecular immunology 65 (1), 58-67, 2015
802015
Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer
A Rami, N Zarghami
Advanced Pharmaceutical Bulletin 3 (1), 127, 2013
742013
Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs
E Karami, M Behdani, F Kazemi-Lomedasht
Journal of Drug Delivery Science and Technology 55, 101471, 2020
692020
An overview on application of phage display technique in immunological studies
A Rami, M Behdani, N Yardehnavi, M Habibi-Anbouhi, ...
Asian Pacific Journal of Tropical Biomedicine 7 (7), 599-602, 2017
672017
The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus
F Kazemi-Lomedasht, V Khalaj, KP Bagheri, M Behdani, ...
Toxicon 125, 123-130, 2017
472017
Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)
V Homayouni, M Ganjalikhani-Hakemi, A Rezaei, H Khanahmad, ...
Iranian Journal of Basic Medical Sciences 19 (11), 1201, 2016
422016
Nanobodies as novel therapeutic agents in envenomation
E Alirahimi, F Kazemi-Lomedasht, D Shahbazzadeh, M Habibi-Anbouhi, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1862 (12), 2955-2965, 2018
412018
Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function
F Kazemi-Lomedasht, S Muyldermans, M Habibi-Anbouhi, M Behdani
Iranian journal of basic medical sciences 21 (3), 260, 2018
332018
A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis
E Karami, JM Sabatier, M Behdani, S Irani, F Kazemi-Lomedasht
Journal of enzyme inhibition and medicinal chemistry 35 (1), 1233-1239, 2020
322020
Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization
A Sadeghi, M Behdani, S Muyldermans, M Habibi‐Anbouhi, ...
Drug testing and analysis 12 (1), 92-100, 2020
322020
Expression and purification of functional human vascular endothelial growth factor-a121; the most important angiogenesis factor
F Kazemi-Lomedasht, M Behdani, KP Bagheri, MH Anbouhi, ...
Advanced Pharmaceutical Bulletin 4 (4), 323, 2014
292014
In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies
F Kazemi-Lomedasht, K Pooshang-Bagheri, M Habibi-Anbouhi, ...
Iranian Journal of Basic Medical Sciences 20 (5), 489, 2017
282017
Production and characterization of novel camel single domain antibody targeting mouse vascular endothelial growth factor
F Kazemi-Lomedasht, M Behdani, M Habibi-Anbouhi, D Shahbazzadeh
Monoclonal antibodies in immunodiagnosis and immunotherapy 35 (3), 167-171, 2016
282016
Development of a recombinant camelid specific diabody against the heminecrolysin fraction of Hemiscorpius lepturus scorpion
M Bagheri, E Babaei, D Shahbazzadeh, M Habibi-Anbouhi, E Alirahimi, ...
Toxin Reviews 36 (1), 7-11, 2017
242017
Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization
E Alirahimi, A Ashkiyan, F Kazemi-Lomedasht, K Azadmanesh, ...
Cancer gene therapy 24 (1), 33-37, 2017
232017
Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy
R Roshan, S Naderi, M Behdani, RA Cohan, H Ghaderi, MA Shokrgozar, ...
Molecular Immunology 129, 70-77, 2021
222021
The inhibitory effect of the combination of two new peptides on biofilm formation by Acinetobacter baumannii
N Irani, E Basardeh, F Samiee, A Fateh, F Shooraj, A Rahimi, ...
Microbial pathogenesis 121, 310-317, 2018
222018
An antibody fragment against human delta-like ligand-4 for inhibition of cell proliferation and neovascularization
R Baharlou, N Tajik, M Behdani, MA Shokrgozar, V Tavana, ...
Immunopharmacology and Immunotoxicology 40 (5), 368-374, 2018
212018
Oligoclonal selection of nanobodies targeting vascular endothelial growth factor
M Ahadi, H Ghasemian, M Behdani, F Kazemi-Lomedasht
Journal of immunotoxicology 16 (1), 34-42, 2019
192019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20